SCHEMBL29948423

SCHEMBL29948423

Sc1ncc2nccnc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387724 1.00
SCHEMBL29452981 0.75
SCHEMBL2009621 0.71 ADORA2A (0.45)
SCHEMBL1233375 0.71 KDM4E (0.42)
SCHEMBL30518193 0.71 RPS6KA5 (0.33)
SCHEMBL3090399 0.71
SCHEMBL17378974 0.71 HDAC8 (0.32)
SCHEMBL291320 0.71
SCHEMBL973036 0.71 BCHE (0.32)
SCHEMBL2009616 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4456921-A2 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-11-06 EP disclosed
EP-4312987-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS Recode Therapeutics, Inc. (US) 2024-02-07 EP disclosed
WO-2023129915-A2 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-07-06 WO disclosed
WO-2022204219-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS RECODE THERAPEUTICS, INC. (US) 2022-09-29 WO disclosed